Patel K - Search Results

1

Insulin resistance is independently associated with significant hepatic fibrosis in Asian chronic hepatitis C genotype 2 or 3 patients.

Patel K, Thompson AJ, Chuang WL, Lee CM, Peng CY, Shanmuganathan G, Thongsawat S, Tanwandee T, Mahachai V, Pramoolsinsap C, Cho M, Han KH, Shah SR, Foster GR, Clark PJ, Pulkstenis E, Subramanian GM, McHutchison JG. Patel K, et al. J Gastroenterol Hepatol. 2011 Jul;26(7):1182-8. doi: 10.1111/j.1440-1746.2011.06722.x. J Gastroenterol Hepatol. 2011. PMID: 21410752 Clinical Trial.

2

Adherence to combination therapy enhances sustained response in genotype-1-infected patients with chronic hepatitis C.

McHutchison JG, Manns M, Patel K, Poynard T, Lindsay KL, Trepo C, Dienstag J, Lee WM, Mak C, Garaud JJ, Albrecht JK; International Hepatitis Interventional Therapy Group. McHutchison JG, et al. Among authors: patel k. Gastroenterology. 2002 Oct;123(4):1061-9. doi: 10.1053/gast.2002.35950. Gastroenterology. 2002. PMID: 12360468

3

Future therapy of hepatitis C.

McHutchison JG, Patel K. McHutchison JG, et al. Among authors: patel k. Hepatology. 2002 Nov;36(5 Suppl 1):S245-52. doi: 10.1053/jhep.2002.36795. Hepatology. 2002. PMID: 12407600 Review.

4

Clinical use of hyaluronic acid as a predictor of fibrosis change in hepatitis C.

Patel K, Lajoie A, Heaton S, Pianko S, Behling CA, Bylund D, Pockros PJ, Blatt LM, Conrad A, McHutchison JG. Patel K, et al. J Gastroenterol Hepatol. 2003 Mar;18(3):253-7. doi: 10.1046/j.1440-1746.2003.02930.x. J Gastroenterol Hepatol. 2003. PMID: 12603524

5

New therapies for chronic hepatitis C virus infection.

Dev A, Patel K, McHutchison JG. Dev A, et al. Among authors: patel k. Curr Gastroenterol Rep. 2004 Feb;6(1):77-86. doi: 10.1007/s11894-004-0030-5. Curr Gastroenterol Rep. 2004. PMID: 14720458 Review.

6

Hepatitis C and steatosis.

Dev A, Patel K, McHutchison JG. Dev A, et al. Among authors: patel k. Clin Liver Dis. 2004 Nov;8(4):881-92, ix. doi: 10.1016/j.cld.2004.06.007. Clin Liver Dis. 2004. PMID: 15464660 Review.

7

Initial treatment for chronic hepatitis C: current therapies and their optimal dosing and duration.

Patel K, McHutchison JG. Patel K, et al. Cleve Clin J Med. 2004 May;71 Suppl 3:S8-12. doi: 10.3949/ccjm.71.suppl_3.s8. Cleve Clin J Med. 2004. PMID: 15468611 Free article. Review.

8

Evaluation of a panel of non-invasive serum markers to differentiate mild from moderate-to-advanced liver fibrosis in chronic hepatitis C patients.

Patel K, Gordon SC, Jacobson I, Hézode C, Oh E, Smith KM, Pawlotsky JM, McHutchison JG. Patel K, et al. J Hepatol. 2004 Dec;41(6):935-42. doi: 10.1016/j.jhep.2004.08.008. J Hepatol. 2004. PMID: 15582126

9

Steatosis and chronic hepatitis C virus infection: mechanisms and significance.

Patel K, Zekry A, McHutchison JG. Patel K, et al. Clin Liver Dis. 2005 Aug;9(3):399-410, vi. doi: 10.1016/j.cld.2005.05.007. Clin Liver Dis. 2005. PMID: 16023973 Review.

10

Relationship of smoking and fibrosis in patients with chronic hepatitis C.

Dev A, Patel K, Conrad A, Blatt LM, McHutchison JG. Dev A, et al. Among authors: patel k. Clin Gastroenterol Hepatol. 2006 Jun;4(6):797-801. doi: 10.1016/j.cgh.2006.03.019. Epub 2006 May 6. Clin Gastroenterol Hepatol. 2006. PMID: 16682255

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

8,791 results

Search Page

Filters